Follow
Marta Grau-Vorster
Marta Grau-Vorster
Banc de Sang i Teixits.
Verified email at bst.cat
Title
Cited by
Cited by
Year
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study
M Grau-Vorster, A Laitinen, J Nystedt, J Vives
Stem cell research & therapy 10, 1-8, 2019
542019
Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly
I Oliver-Vila, MI Coca, M Grau-Vorster, N Pujals-Fonts, M Caminal, ...
Cytotherapy 18 (1), 25-35, 2016
542016
Optimisation of a potency assay for the assessment of immunomodulative potential of clinical grade multipotent mesenchymal stromal cells
I Oliver-Vila, C Ramírez-Moncayo, M Grau-Vorster, S Marín-Gallén, ...
Cytotechnology 70, 31-44, 2018
272018
Compliance with good manufacturing practice in the assessment of immunomodulation potential of clinical grade multipotent mesenchymal stromal cells derived from Wharton’s Jelly
M Grau-Vorster, L Rodríguez, A del Mazo-Barbara, C Mirabel, M Blanco, ...
Cells 8 (5), 484, 2019
252019
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow–derived multipotent mesenchymal stromal cell expansion cultures
M Grau-Vorster, L Rodríguez, S Torrents-Zapata, D Vivas, M Codinach, ...
Cytotherapy 21 (1), 32-40, 2019
242019
Characterization of a cytomegalovirus-specific T lymphocyte product obtained through a rapid and scalable production process for use in adoptive immunotherapy
M Grau-Vorster, M López-Montañés, E Cantó, J Vives, I Oliver-Vila, ...
Frontiers in immunology 11, 488349, 2020
102020
Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineering
D Vivas, M Grau-Vorster, I Oliver-Vila, J García-López, J Vives
Molecular Biology Reports 47 (7), 5145-5154, 2020
42020
Illustrative Potency Assay Examples from Approved Therapies
S Torrents, M Grau-Vorster, J Vives
Potency Assays for Advanced Stem Cell Therapy Medicinal Products, 139-149, 2023
12023
Off-the-shelf mesenchymal stromal cells derived from umbilical cord tissue
I Oliver-Vila, MI Coca, M Grau-Vorster, N Pujals-Fonts, M Caminal, A Pla, ...
BMC Proceedings 9 (Suppl 9), P65, 2015
12015
Potency Assays: The ‘Bugaboo’of Stem Cell Therapy
S Torrents, M Grau-Vorster, J Vives
Potency Assays for Advanced Stem Cell Therapy Medicinal Products, 29-38, 2023
2023
Development and characterisation of advanced cell therapies based on multipotent mesenchymal stromal cells and virus-specific T lymphocytes
M Grau-Vorster
2020
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells
M Grau-Vorster, A Laitinen, J Nystedt, J Vives Armengol
2019
Optimization of methods for ex vivo expansion of T-cells for adoptive immunotherapy
M Grau-Vorster, A del Mazo-Barbara, D Vivas-Pradillo, C Mirabel, ...
Cytotherapy 19 (5), S36, 2017
2017
number of doses of CMV-specific cytotoxic T cells was successfully performed.
M Grau-Vorster, M López-Montañés, E Cantó, J Vives, I Oliver-Vila, ...
The system can't perform the operation now. Try again later.
Articles 1–14